TY - JOUR
T1 - Brief Report
T2 - Cystatin C-Based Estimation of Glomerular Filtration Rate and Association with Atherosclerosis Imaging Markers in People Living with HIV
AU - McClean, Mitchell
AU - Buzkova, Petra
AU - Budoff, Matthew
AU - Estrella, Michelle
AU - Freiberg, Matthew
AU - Palella, Frank
AU - Shikuma, Cecilia
AU - Post, Wendy S.
AU - Gupta, Samir
AU - Gupta, Samir
N1 - Funding Information:
Supported in part by the HIV-CVD Collaborative Data Coordinating Center, funded by the NIH/NHLBI R01HL095126. The MACS CVD2 study is funded by the National Heart, Lung and Blood Institute (NHLBI), R01 HL095129 (Post), with additional support from UL1 TR 001079 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) with centers (Principal Investigators) at Johns Hopkins University Bloomberg School of Public Health (Joseph Margolick), U01-AI35042; Northwestern University (Steven Wolinsky), U01-AI35039; University of California, Los Angeles (Roger Detels), U01-AI35040; University of Pittsburgh (Charles Rinaldo), U01-AI35041; the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health (Lisa Jacobson), UM1-AI35043. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also sup-ported by UL1 TR 001079 (JHU CTSA) and UL1-TR000124 (Harbor-UCLA CTSA). Website: http://www.statepi.jhsph.edu/macs/macs.html . The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH).
Publisher Copyright:
© 2020 Lippincott Williams and Wilkins. All rights reserved.
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Introduction:Reduced estimated glomerular filtration rate (eGFR) is associated with increased risk of cardiovascular disease among people living with HIV (PLWH). It is unclear whether eGFR equations incorporating cystatin C (CysC) measurements are more predictive of preclinical cardiovascular disease than those using only creatinine (Cr).Objectives:The study aimed to determine which of the 3 Chronic Kidney Disease Epidemiology (CKD-EPI) eGFR equations is most associated with carotid intima media thickness (CIMT) and coronary artery calcium (CAC) score.Methods:This cross-sectional analysis of pooled data from 3 large cohorts compared the associations between the 3 CKD-EPI eGFR equations (Cr, CysC, and Cr-CysC) with CIMT and CAC score using multivariable regression analysis. eGFR and CIMT were analyzed as continuous variables. CAC scores were analyzed as a binary variable (detectable calcification versus nondetectable) and as a log10 Agatston score in those with detectable CAC.Results:Thousand four hundred eighty-seven participants were included, and of these 910 (562 HIV+ and 348 HIV-) had CIMT measurements and 366 (296 HIV+ and 70 HIV-) had CAC measurements available. In HIV-participants, GFR estimated by any CKD-EPI equation did not significantly correlate with CIMT or CAC scores. When PLWH were analyzed separately including HIV-specific factors, only GFR estimated using Cr-Cys C correlated with CIMT [β=-0.90, 95% CI: (-1.67 to-0.13) m; P = 0.023]. Similarly, eGFR correlated with Agatston scores only when using cystatin C-based eGFR [β=-8.63, 95% CI: (-16.49 to-0.77) HU; P = 0.034]. Associations between other eGFR formulas and CAC did not reach statistical significance.Conclusions:In PLWH, preclinical atherosclerosis may be more closely correlated with eGFR using formulae that incorporate CysC measurements than Cr alone.
AB - Introduction:Reduced estimated glomerular filtration rate (eGFR) is associated with increased risk of cardiovascular disease among people living with HIV (PLWH). It is unclear whether eGFR equations incorporating cystatin C (CysC) measurements are more predictive of preclinical cardiovascular disease than those using only creatinine (Cr).Objectives:The study aimed to determine which of the 3 Chronic Kidney Disease Epidemiology (CKD-EPI) eGFR equations is most associated with carotid intima media thickness (CIMT) and coronary artery calcium (CAC) score.Methods:This cross-sectional analysis of pooled data from 3 large cohorts compared the associations between the 3 CKD-EPI eGFR equations (Cr, CysC, and Cr-CysC) with CIMT and CAC score using multivariable regression analysis. eGFR and CIMT were analyzed as continuous variables. CAC scores were analyzed as a binary variable (detectable calcification versus nondetectable) and as a log10 Agatston score in those with detectable CAC.Results:Thousand four hundred eighty-seven participants were included, and of these 910 (562 HIV+ and 348 HIV-) had CIMT measurements and 366 (296 HIV+ and 70 HIV-) had CAC measurements available. In HIV-participants, GFR estimated by any CKD-EPI equation did not significantly correlate with CIMT or CAC scores. When PLWH were analyzed separately including HIV-specific factors, only GFR estimated using Cr-Cys C correlated with CIMT [β=-0.90, 95% CI: (-1.67 to-0.13) m; P = 0.023]. Similarly, eGFR correlated with Agatston scores only when using cystatin C-based eGFR [β=-8.63, 95% CI: (-16.49 to-0.77) HU; P = 0.034]. Associations between other eGFR formulas and CAC did not reach statistical significance.Conclusions:In PLWH, preclinical atherosclerosis may be more closely correlated with eGFR using formulae that incorporate CysC measurements than Cr alone.
KW - Cardiovascular disease
KW - Carotid intima media thickness
KW - Coronary artery calcium
KW - Cystatin C
KW - Glomerular filtration rate
KW - HIV-1
UR - http://www.scopus.com/inward/record.url?scp=85095404225&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85095404225&partnerID=8YFLogxK
U2 - 10.1097/QAI.0000000000002467
DO - 10.1097/QAI.0000000000002467
M3 - Article
C2 - 33136746
AN - SCOPUS:85095404225
SN - 1525-4135
VL - 85
SP - 466
EP - 469
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 4
ER -